Shipping and logistics considerations for regenerative medicine therapies
T Criswell, C Swart, J Stoudemire… - Stem Cells …, 2022 - academic.oup.com
Advances in regenerative medicine manufacturing continue to be a priority for achieving the
full commercial potential of important breakthrough therapies. Equally important will be the …
full commercial potential of important breakthrough therapies. Equally important will be the …
An industry-driven roadmap for manufacturing in regenerative medicine
JG Hunsberger, T Shupe, A Atala - Stem cells translational …, 2018 - academic.oup.com
Regenerative medicine is poised to become a significant industry within the medical field. As
such, the development of strategies and technologies for standardized and automated …
such, the development of strategies and technologies for standardized and automated …
Manufacturing challenges in regenerative medicine
I Martin, PJ Simmons, DF Williams - Science translational medicine, 2014 - science.org
Manufacturing Challenges in Regenerative Medicine | Science Translational Medicine news
careers commentary Journals Science Science brought to you byGoogle Indexer Log in science …
careers commentary Journals Science Science brought to you byGoogle Indexer Log in science …
[HTML][HTML] From production to patient: challenges and approaches for delivering cell therapies
K Coopman, N Medcalf - 2014 - europepmc.org
The cell therapy industry is rapidly growing with several new products approved for clinical
use over the past few years and many more currently in clinical trials. Nonetheless, a …
use over the past few years and many more currently in clinical trials. Nonetheless, a …
An analysis of supply chain strategies in the regenerative medicine industry—implications for future development
CW Teng, L Foley, P O'Neill, C Hicks - International Journal of Production …, 2014 - Elsevier
The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …
Regenerative medicine manufacturing—challenges and opportunities
P Cohen, JG Hunsberger, A Atala - Principles of Regenerative Medicine, 2019 - Elsevier
This chapter will cover the challenges and opportunities in regenerative medicine
manufacturing. We will start with a brief background on the importance of advancing …
manufacturing. We will start with a brief background on the importance of advancing …
Cell therapy products are revolutionizing multiple therapeutic areas; to maintain this pace of innovation, manufacturing solutions must adapt
E Abraham, N Trainor, N Ostrout, MM Hewitt - Current Opinion in …, 2021 - Elsevier
Although cell therapies continue to reshape multiple therapeutics areas, the field is still
grappling with how to best manufacture therapies. Allogeneic therapies are currently …
grappling with how to best manufacture therapies. Allogeneic therapies are currently …
Manufacturing road map for tissue engineering and regenerative medicine technologies
Abstract Summary The Regenerative Medicine Foundation Annual Conference held on May
6 and 7, 2014, had a vision of assisting with translating tissue engineering and regenerative …
6 and 7, 2014, had a vision of assisting with translating tissue engineering and regenerative …
[HTML][HTML] Decentralized manufacturing of cell and gene therapies: Overcoming challenges and identifying opportunities
RP Harrison, S Ruck, N Medcalf, QA Rafiq - Cytotherapy, 2017 - Elsevier
Decentralized or “redistributed” manufacturing has the potential to revolutionize the
manufacturing approach for cell and gene therapies (CGTs), moving away from the “Fordist” …
manufacturing approach for cell and gene therapies (CGTs), moving away from the “Fordist” …
[PDF][PDF] Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine
E Ratcliffe, RJ Thomas, DJ Williams - British medical bulletin, 2011 - researchgate.net
Background: A novel manufacturing industry is emerging to translate unique cellular therapy
bioprocesses to robust, scaled manufacturing production for successful clinical translation …
bioprocesses to robust, scaled manufacturing production for successful clinical translation …